Bright Minds Biosciences Inc (DRUG)

Currency in CAD
44.69
-1.31(-2.85%)
Delayed Data·
DRUG Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
DRUG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
44.6944.69
52 wk Range
1.30108.00
Key Statistics
Bid/Ask
1.47 / 1.78
Prev. Close
1.39
Open
44.69
Day's Range
44.69-44.69
52 wk Range
1.3-108
Volume
150
Average Volume (3m)
755
1-Year Change
2,982.07%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DRUG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
80.00
Upside
+79.01%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Bright Minds Biosciences Inc Company Profile

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry; and BMB-101 which completes phase 1 trial for undisclosed seizure disorder. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatry and neurology indications. Bright Minds Biosciences Inc. has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was founded in 2017 and is headquartered in New York, New York.

Compare DRUG to Peers and Sector

Metrics to compare
DRUG
Peers
Sector
Relationship
P/E Ratio
−91.9x−2.6x−0.5x
PEG Ratio
−1.74−0.110.00
Price/Book
5.7x0.9x2.6x
Price / LTM Sales
-10.0x3.3x
Upside (Analyst Target)
79.0%394.0%43.5%
Fair Value Upside
Unlock11.7%6.9%Unlock

Analyst Ratings

6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 80.00
(+79.01% Upside)

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-0.42 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

DRUG Income Statement

FAQ

What Stock Exchange Does Bright Minds Biosciences Trade On?

Bright Minds Biosciences is listed and trades on the Canadian Securities Exchange stock exchange.

What Is the Stock Symbol for Bright Minds Biosciences?

The stock symbol for Bright Minds Biosciences is "DRUG."

What Is the Bright Minds Biosciences Market Cap?

As of today, Bright Minds Biosciences market cap is 316.55M.

What Is Bright Minds Biosciences's Earnings Per Share (TTM)?

The Bright Minds Biosciences EPS (TTM) is -0.62.

From a Technical Analysis Perspective, Is DRUG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Bright Minds Biosciences Stock Split?

Bright Minds Biosciences has split 1 times.

How Many Employees Does Bright Minds Biosciences Have?

Bright Minds Biosciences has 0 employees.

What is the current trading status of Bright Minds Biosciences (DRUG)?

As of 07 Aug 2025, Bright Minds Biosciences (DRUG) is trading at a price of 44.69, with a previous close of 1.39. The stock has fluctuated within a day range of 44.69 to 44.69, while its 52-week range spans from 1.30 to 108.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.